HALLETT DAVID (Chief Scientific Officer) reported 1 transaction at RECURSION PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/19/2026ACC: 0001601830-26-000022
Officer· Chief Scientific Officer
Since Feb 2026
-11.91K
Net shares
Net seller
$41.6K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
11.91K disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−11.91K
Price / share
$3.49
Trade value
$41.56K
% of position
1.1%
2/17/2026
1.11M→1.10M
Total
Net shares
−11.91K
Net value
-$41.56K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 2/17/2026 | F · Tax Withholding | −11.91K | $3.49 | $41.56K | 1.1% | 1.11M | 1.10M |
| Total | −11.91K | -$41.56K | ||||||
Derivative Transactions0
No derivative transactions reported